Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 15 | 2018 | 66 | 3.000 |
Why?
|
| Erythrocyte Transfusion | 16 | 2022 | 75 | 2.780 |
Why?
|
| Anemia | 14 | 2022 | 117 | 1.870 |
Why?
|
| High-Frequency Ventilation | 4 | 2016 | 5 | 1.770 |
Why?
|
| Critical Illness | 18 | 2022 | 333 | 1.700 |
Why?
|
| Respiratory Insufficiency | 4 | 2018 | 152 | 1.170 |
Why?
|
| Child | 29 | 2023 | 4313 | 1.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 52 | 0.850 |
Why?
|
| Hospice Care | 1 | 2023 | 61 | 0.830 |
Why?
|
| Hospitalization | 3 | 2017 | 1287 | 0.830 |
Why?
|
| Palliative Care | 1 | 2023 | 212 | 0.750 |
Why?
|
| Evidence-Based Medicine | 13 | 2022 | 454 | 0.740 |
Why?
|
| Respiration, Artificial | 4 | 2016 | 293 | 0.680 |
Why?
|
| Isoflurane | 2 | 2012 | 15 | 0.680 |
Why?
|
| Anesthetics, Inhalation | 2 | 2012 | 18 | 0.670 |
Why?
|
| Critical Care | 15 | 2022 | 413 | 0.610 |
Why?
|
| Child, Preschool | 13 | 2018 | 1836 | 0.610 |
Why?
|
| Hemoglobins | 3 | 2018 | 138 | 0.600 |
Why?
|
| Hemorrhage | 4 | 2022 | 268 | 0.560 |
Why?
|
| Infant | 11 | 2022 | 1524 | 0.540 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2016 | 9 | 0.520 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 151 | 0.500 |
Why?
|
| Hypoxia | 1 | 2016 | 108 | 0.480 |
Why?
|
| Antidotes | 1 | 2014 | 20 | 0.460 |
Why?
|
| Poisoning | 1 | 2014 | 29 | 0.450 |
Why?
|
| Attitude to Death | 1 | 2012 | 17 | 0.410 |
Why?
|
| Group Processes | 1 | 2012 | 41 | 0.400 |
Why?
|
| Humans | 35 | 2023 | 59512 | 0.400 |
Why?
|
| Bronchial Spasm | 1 | 2012 | 7 | 0.400 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 59 | 0.400 |
Why?
|
| Phlebotomy | 1 | 2012 | 8 | 0.390 |
Why?
|
| Naloxone | 1 | 2011 | 54 | 0.350 |
Why?
|
| Narcotic Antagonists | 1 | 2011 | 114 | 0.330 |
Why?
|
| Environmental Exposure | 1 | 2011 | 205 | 0.330 |
Why?
|
| Consensus Development Conferences as Topic | 2 | 2018 | 14 | 0.310 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 715 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 705 | 0.300 |
Why?
|
| Infant, Newborn | 7 | 2018 | 1306 | 0.300 |
Why?
|
| Buprenorphine | 1 | 2011 | 186 | 0.290 |
Why?
|
| Athetosis | 1 | 2007 | 2 | 0.280 |
Why?
|
| Atracurium | 1 | 2007 | 2 | 0.280 |
Why?
|
| Status Asthmaticus | 1 | 2007 | 7 | 0.280 |
Why?
|
| Chorea | 1 | 2007 | 10 | 0.280 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2007 | 13 | 0.280 |
Why?
|
| Adolescent | 7 | 2018 | 5922 | 0.250 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2007 | 117 | 0.250 |
Why?
|
| Internship and Residency | 1 | 2012 | 734 | 0.240 |
Why?
|
| Age Distribution | 2 | 2014 | 261 | 0.200 |
Why?
|
| Community Health Services | 1 | 2023 | 128 | 0.200 |
Why?
|
| New England | 2 | 2014 | 268 | 0.200 |
Why?
|
| Male | 10 | 2016 | 27582 | 0.190 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 34 | 0.190 |
Why?
|
| Transfusion Reaction | 2 | 2018 | 46 | 0.190 |
Why?
|
| Liquid Ventilation | 1 | 2001 | 4 | 0.190 |
Why?
|
| Supine Position | 1 | 2001 | 31 | 0.180 |
Why?
|
| Fluoroscopy | 1 | 2001 | 61 | 0.180 |
Why?
|
| Prone Position | 1 | 2001 | 27 | 0.180 |
Why?
|
| Fluorocarbons | 1 | 2001 | 33 | 0.180 |
Why?
|
| Drug Monitoring | 1 | 2001 | 96 | 0.180 |
Why?
|
| Pain | 1 | 2023 | 405 | 0.180 |
Why?
|
| Blood Specimen Collection | 2 | 2012 | 17 | 0.170 |
Why?
|
| Female | 9 | 2016 | 30914 | 0.160 |
Why?
|
| Thalassemia | 1 | 2018 | 4 | 0.160 |
Why?
|
| Anemia, Hemolytic | 1 | 2018 | 11 | 0.160 |
Why?
|
| Shock, Hemorrhagic | 1 | 2018 | 19 | 0.150 |
Why?
|
| Shock | 1 | 2018 | 31 | 0.150 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 23 | 0.150 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 61 | 0.150 |
Why?
|
| Health Personnel | 1 | 2021 | 343 | 0.150 |
Why?
|
| Epidermolysis Bullosa Dystrophica | 1 | 2017 | 14 | 0.140 |
Why?
|
| Length of Stay | 2 | 2014 | 768 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2018 | 147 | 0.140 |
Why?
|
| Graft vs Host Disease | 1 | 2018 | 99 | 0.140 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 96 | 0.140 |
Why?
|
| Patient Care | 1 | 2017 | 78 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2016 | 3102 | 0.140 |
Why?
|
| Splenic Neoplasms | 1 | 2016 | 7 | 0.130 |
Why?
|
| Quality of Life | 1 | 2023 | 1118 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2014 | 6013 | 0.130 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 126 | 0.130 |
Why?
|
| Time Factors | 3 | 2016 | 3583 | 0.130 |
Why?
|
| Propensity Score | 1 | 2016 | 133 | 0.120 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 104 | 0.120 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 114 | 0.120 |
Why?
|
| Erythrocyte Count | 3 | 2018 | 14 | 0.120 |
Why?
|
| Sepsis | 1 | 2018 | 281 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2012 | 1915 | 0.120 |
Why?
|
| Accidents | 1 | 2014 | 12 | 0.120 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 672 | 0.110 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 238 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2016 | 773 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 2073 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 277 | 0.110 |
Why?
|
| Risk Factors | 3 | 2012 | 5014 | 0.110 |
Why?
|
| Suicide, Attempted | 1 | 2014 | 103 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 318 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 404 | 0.100 |
Why?
|
| Terminally Ill | 1 | 2012 | 17 | 0.100 |
Why?
|
| Intensive Care Units | 1 | 2016 | 449 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 674 | 0.100 |
Why?
|
| Platelet Transfusion | 2 | 2022 | 12 | 0.100 |
Why?
|
| Drug Overdose | 1 | 2014 | 120 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 315 | 0.100 |
Why?
|
| Respiratory Function Tests | 1 | 2012 | 165 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 53 | 0.090 |
Why?
|
| Cause of Death | 1 | 2012 | 199 | 0.090 |
Why?
|
| Canada | 2 | 2010 | 147 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2012 | 254 | 0.090 |
Why?
|
| Drug Storage | 1 | 2011 | 21 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1454 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 422 | 0.090 |
Why?
|
| Medical Audit | 1 | 2011 | 60 | 0.090 |
Why?
|
| Electronic Health Records | 1 | 2014 | 352 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 555 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 427 | 0.090 |
Why?
|
| Blood Gas Analysis | 2 | 2018 | 34 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2011 | 344 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2010 | 154 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2012 | 5180 | 0.080 |
Why?
|
| Patient Safety | 1 | 2012 | 244 | 0.080 |
Why?
|
| Neoplasms | 1 | 2018 | 1250 | 0.080 |
Why?
|
| Incidence | 1 | 2012 | 1242 | 0.080 |
Why?
|
| Clinical Decision-Making | 2 | 2018 | 141 | 0.070 |
Why?
|
| Ventilator Weaning | 1 | 2007 | 18 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2012 | 2443 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 2591 | 0.060 |
Why?
|
| Blood Component Transfusion | 1 | 2022 | 8 | 0.050 |
Why?
|
| Young Adult | 1 | 2012 | 4326 | 0.050 |
Why?
|
| Plasma | 1 | 2022 | 33 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2022 | 95 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2329 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2001 | 15 | 0.050 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2001 | 41 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 2001 | 57 | 0.050 |
Why?
|
| Respiratory Mechanics | 1 | 2001 | 53 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2001 | 96 | 0.040 |
Why?
|
| Random Allocation | 1 | 2001 | 197 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2001 | 283 | 0.040 |
Why?
|
| Ventilators, Mechanical | 1 | 2000 | 31 | 0.040 |
Why?
|
| Lung Injury | 1 | 2000 | 32 | 0.040 |
Why?
|
| Swine | 1 | 2001 | 348 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2001 | 235 | 0.040 |
Why?
|
| IgA Deficiency | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2018 | 7 | 0.040 |
Why?
|
| Vital Signs | 1 | 2018 | 11 | 0.040 |
Why?
|
| United States | 2 | 2010 | 7530 | 0.040 |
Why?
|
| Decision Trees | 1 | 2018 | 52 | 0.040 |
Why?
|
| Acute Disease | 1 | 2000 | 658 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 75 | 0.040 |
Why?
|
| Survival Rate | 1 | 2000 | 790 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 195 | 0.040 |
Why?
|
| Animals | 3 | 2016 | 19654 | 0.030 |
Why?
|
| Albumins | 1 | 2016 | 32 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2016 | 39 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2016 | 90 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 260 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 181 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 196 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 138 | 0.030 |
Why?
|
| Dependovirus | 1 | 2022 | 655 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2016 | 163 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2022 | 738 | 0.030 |
Why?
|
| Inpatients | 1 | 2017 | 296 | 0.030 |
Why?
|
| Skin | 1 | 2017 | 356 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1516 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 941 | 0.020 |
Why?
|
| Materials Management, Hospital | 1 | 2010 | 2 | 0.020 |
Why?
|
| Adult | 1 | 2000 | 15776 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 10273 | 0.010 |
Why?
|